Letters
NICE clinical guidelines: Maybe health economists should participate in guideline development
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7465.571 (Published 02 September 2004) Cite this as: BMJ 2004;329:571- Peter Littlejohns, clinical director (peter.littlejohns@nice.nhs.uk),
- Gillian Leng, guidelines programme director,
- Tony Culyer, chief scientist,
- Mike Drummond, director
- National Institute for Clinical Excellence, London WC1V 6NA
- National Institute for Clinical Excellence, London WC1V 6NA
- Institute for Work and Health, Toronto
- Centre for Health Economics, University of York
EDITOR—Wailoo et al highlight a fundamental challenge that the National Institute for Clinical Excellence (NICE) faces on a daily basis.1 The government established NICE not only to advise the NHS on the quality of care that individual patients could expect (in terms of appropriateness and effectiveness) but also to address the other important dimensions of healthcare quality (equity, fairness, and efficiency) that society expects.
We agree that being required to address both …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.